Socioeconomic Distress Associated With Increased Use of Percutaneous Coronary Intervention Over Coronary Artery Bypass Grafting.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
04 2023
Historique:
received: 11 02 2022
revised: 01 06 2022
accepted: 18 06 2022
medline: 28 3 2023
pubmed: 23 7 2022
entrez: 22 7 2022
Statut: ppublish

Résumé

The influence of socioeconomic determinants of health on choice of percutaneous coronary intervention (PCI) vs coronary artery bypass grafting (CABG) for coronary artery disease is unknown. We hypothesized that higher Distressed Communities Index (DCI) scores, a comprehensive socioeconomic ranking by zip code, would be associated with more frequent PCI. All patients undergoing isolated CABG or PCI in a regional American College of Cardiology CathPCI registry and The Society of Thoracic Surgeons database (2018-2021) were assigned DCI scores (0 = no distress, 100 = severe distress) based on education level, poverty, unemployment, housing vacancies, median income, and business growth. Patients who presented with ST-segment elevation myocardial infarction or emergent procedures were excluded. The most distressed quintile (DCI ≥80) was compared with all other patients. Multivariable logistic regression analyzed the association between DCI and procedure type. A total of 23 223 patients underwent either PCI (n = 16 079) or CABG (n = 7144) for coronary artery disease across 28 centers during the study period. Before adjustment, high socioeconomic distress occurred more frequently among CABG patients (DCI ≥80, 12.4% vs 8.42%; P < .001). After multivariable adjustment, high socioeconomic distress was associated with greater odds of receiving PCI, relative to CABG (odds ratio 1.26; 95% CI, 1.07-1.49; P = .007). High socioeconomic distress was significantly associated with postprocedural mortality (odds ratio 1.52; 95% CI, 1.02-2.26; P = .039). High socioeconomic distress is associated with greater risk-adjusted odds of receiving PCI, relative to CABG, as well as higher postprocedural mortality. Targeted resource allocation in high DCI areas may help eliminate barriers to CABG.

Sections du résumé

BACKGROUND
The influence of socioeconomic determinants of health on choice of percutaneous coronary intervention (PCI) vs coronary artery bypass grafting (CABG) for coronary artery disease is unknown. We hypothesized that higher Distressed Communities Index (DCI) scores, a comprehensive socioeconomic ranking by zip code, would be associated with more frequent PCI.
METHODS
All patients undergoing isolated CABG or PCI in a regional American College of Cardiology CathPCI registry and The Society of Thoracic Surgeons database (2018-2021) were assigned DCI scores (0 = no distress, 100 = severe distress) based on education level, poverty, unemployment, housing vacancies, median income, and business growth. Patients who presented with ST-segment elevation myocardial infarction or emergent procedures were excluded. The most distressed quintile (DCI ≥80) was compared with all other patients. Multivariable logistic regression analyzed the association between DCI and procedure type.
RESULTS
A total of 23 223 patients underwent either PCI (n = 16 079) or CABG (n = 7144) for coronary artery disease across 28 centers during the study period. Before adjustment, high socioeconomic distress occurred more frequently among CABG patients (DCI ≥80, 12.4% vs 8.42%; P < .001). After multivariable adjustment, high socioeconomic distress was associated with greater odds of receiving PCI, relative to CABG (odds ratio 1.26; 95% CI, 1.07-1.49; P = .007). High socioeconomic distress was significantly associated with postprocedural mortality (odds ratio 1.52; 95% CI, 1.02-2.26; P = .039).
CONCLUSIONS
High socioeconomic distress is associated with greater risk-adjusted odds of receiving PCI, relative to CABG, as well as higher postprocedural mortality. Targeted resource allocation in high DCI areas may help eliminate barriers to CABG.

Identifiants

pubmed: 35868555
pii: S0003-4975(22)00969-9
doi: 10.1016/j.athoracsur.2022.06.040
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

914-921

Informations de copyright

Copyright © 2023 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Raymond J Strobel (RJ)

Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.

J Hunter Mehaffey (JH)

Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.

Robert B Hawkins (RB)

Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.

Andrew M Young (AM)

Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.

Erik J Scott (EJ)

Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.

Mohammed Quader (M)

Division of Cardiothoracic Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia.

Gregory J Dehmer (GJ)

Department of Medicine Carilion Clinic/Virginia Tech Carilion School of Medicine, Roanoke, Virginia.

Jeffrey B Rich (JB)

Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.

Gorav Ailawadi (G)

Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.

Irving L Kron (IL)

Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.

Michael Ragosta (M)

Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia.

Leora T Yarboro (LT)

Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.

Nicholas R Teman (NR)

Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia. Electronic address: nrt4c@virginia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH